Bioorthogonal chemistry for selective recognition, separation and killing bacteria over mammalian cells.

Zhenhua Li,Zhen Liu,Zhaowei Chen,Enguo Ju,Wei Li,Jinsong Ren,Xiaogang Qu

DOI: https://doi.org/10.1039/c5cc10625g

IF: 4.9

2016-01-01

Chemical Communications

Abstract:By taking advantage of metabolic engineering and bioorthogonal click chemistry, we report a new strategy for selective recognition, separation and killing bacteria over mammalian cells.

What problem does this paper attempt to address?

Selective treatment of intracellular bacterial infections using host cell-targeted bioorthogonal nanozymes

Joseph Hardie,Jessa Marie Makabenta,Aarohi Gupta,Rui Huang,Roberto Cao-Milán,Ritabrita Goswami,Xianzhi Zhang,Parvati Abdulpurkar,Michelle E Farkas,Vincent M Rotello

DOI: https://doi.org/10.1039/d1mh02042k

2022-05-10

Abstract:Intracellular bacterial infections are difficult to treat, and in the case of Salmonella and related infections, can be life threatening. Antibiotic treatments for intracellular infections face challenges including cell penetration and intracellular degradation that both reduce antibiotic efficacy. Even when treatable, the increased dose of antibiotics required to counter infections can strongly impact the microbiome, compromising the native roles of beneficial non-pathogenic species. Bioorthogonal catalysis provides a new tool to combat intracellular infections. Catalysts embedded in the monolayers of gold nanoparticles (nanozymes) bioorthogonally convert inert antibiotic prodrugs (pro-antibiotics) into active species within resident macrophages. Targeted nanozyme delivery to macrophages was achieved through mannose conjugation and subsequent uptake VIA the mannose receptor (CD206). These nanozymes efficiently converted pro-ciprofloxacin to ciprofloxacin inside the macrophages, selectively killing pathogenic Salmonella enterica subsp. enterica serovar Typhimurium relative to non-pathogenic Lactobacillus sp. in a transwell co-culture model. Overall, this targeted bioorthogonal nanozyme strategy presents an effective treatment for intracellular infections, including typhoid and tuberculosis.
On-Demand Activatable and Integrated Bioorthogonal Nanocatalyst against Biofilm-Associated Infections

Yue Sun,Huisi Zhao,Fang Pu,Hao Liu,Li Chen,Jinsong Ren,Xiaogang Qu

DOI: https://doi.org/10.1002/adhm.202400899

Abstract:Bioorthogonal chemistry has emerged as a powerful tool for manipulating biological processes. However, difficulties in controlling the exact location and on-demand catalytic synthesis limit its application in biological systems. Herein, this work constructs an activatable bioorthogonal system integrating a shielded catalyst and prodrug molecules to combat biofilm-associated infections. The catalytic species is activated in response to the hyaluronidase (HAase) secreted by the bacteria and the acidic pH of the biofilm, which is accompanied by the release of prodrugs, to achieve the bioorthogonal catalytic synthesis of antibacterial molecules in situ. Moreover, the system can produce reactive oxygen species (ROS) to disperse bacterial biofilms, enabling the antibacterial molecules to penetrate the biofilm and eliminate the bacteria within it. This study promotes the design of efficient and safe bioorthogonal catalysts and the development of bioorthogonal chemistry-mediated antibacterial strategies.
Bioorthogonal reactions and AIEgen-based metabolically engineered theranostic systems

Kenry,Bin Liu

DOI: https://doi.org/10.1016/j.chempr.2023.04.004

IF: 23.5

2023-05-01

Chem

Abstract:Metabolic labeling based on bioorthogonal click chemistry has transformed the way living entities are manipulated in biological environments to enable more targeted, effective, and safer theranostic applications. Since the first demonstrations of this strategy, many other metabolic labeling approaches have been formulated to incorporate additional functionalities, such as those based on fluorogens with aggregation-induced emission characteristic (AIEgens), for light-up bioimaging and image-guided disease therapy. In this perspective, we discuss the emergence and development of AIEgen-based theranostic systems for bioorthogonal metabolic engineering and labeling. First, we highlight the fundamental principles guiding the design of AIEgen-based bioorthogonal metabolic labeling. Next, we describe the formulation and applications of different AIEgen-based synthetic and living theranostic systems for cancer and pathogenic bacterial imaging and ablation. We then provide our outlook on the current challenges, potential opportunities, and future research directions of this emerging field.

chemistry, multidisciplinary
Bioorthogonal Reactions in Bioimaging

Eszter Kozma,Péter Kele,Kele, Péter

DOI: https://doi.org/10.1007/s41061-024-00452-1

2024-02-25

Topics in Current Chemistry

Abstract:Visualization of biomolecules in their native environment or imaging-aided understanding of more complex biomolecular processes are one of the focus areas of chemical biology research, which requires selective, often site-specific labeling of targets. This challenging task is effectively addressed by bioorthogonal chemistry tools in combination with advanced synthetic biology methods. Today, the smart combination of the elements of the bioorthogonal toolbox allows selective installation of multiple markers to selected targets, enabling multicolor or multimodal imaging of biomolecules. Furthermore, recent developments in bioorthogonally applicable probe design that meet the growing demands of superresolution microscopy enable more complex questions to be addressed. These novel, advanced probes enable highly sensitive, low-background, single- or multiphoton imaging of biological species and events in live organisms at resolutions comparable to the size of the biomolecule of interest. Herein, the latest developments in bioorthogonal fluorescent probe design and labeling schemes will be discussed in the context of in cellulo/in vivo (multicolor and/or superresolved) imaging schemes. The second part focuses on the importance of genetically engineered minimal bioorthogonal tags, with a particular interest in site-specific protein tagging applications to answer biological questions.

chemistry, multidisciplinary
Antibody Mimics as Bio-orthogonal Catalysts for Highly Selective Bacterial Recognition and Antimicrobial Therapy

Jingsheng Niu,Liangpeng Wang,Tingting Cui,Zhao Wang,Chuanqi Zhao,Jinsong Ren,Xiaogang Qu

DOI: https://doi.org/10.1021/acsnano.1c03387

IF: 17.1

2021-10-01

ACS Nano

Abstract:Bacterial infectious diseases seriously threaten public health and life. The specific interaction between an antibody and its multivalent antigen is an attractive way to defeat infectious disease. However, due to the high expense and strict storage and applied conditions for antibodies, it is highly desirable but remains an urgent challenge for disease diagnosis and treatment to construct artificial antibodies with strong stability and binding ability and excellent selectivity. Herein, we designed and synthesized antibody-like bio-orthogonal catalysts with the ability to recognize specific bacteria and accomplish in situ drug synthesis in captured bacteria by using improved bacterial imprinting technology. On one hand, the artificial antibody possesses a matching morphology for binding pathogens, and on the other hand, it acts as a bio-orthogonal catalyst for in situ synthesis of antibacterial drugs in live bacteria. Both in vitro and in vivo experiments have demonstrated that our designed antibody can distinguish and selectively bind to specific pathogens and eliminate them on site with the activated drugs. Therefore, our work provides a strategy for designing artificial antibodies with bio-orthogonal catalytic activity and may broaden the application of bio-orthogonal chemistry.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsnano.1c03387.Materials, measurements, experimental details of antibacterial experiments and in vivo experiment, histology, zeta potentials, SEM images, TEM images and corresponding elemental mappings, click reaction of 3-azido-7-hydroxycoumarin 1 and phenylacetylene 2, synthetic route of precursor molecules 4 and 5 and compound 6, 1H NMR, liquid chromatography–mass spectrometry analysis, and in vivo antibacterial activity against E. coli, Figure S1–S47. (PDF)This article has not yet been cited by other publications.

materials science, multidisciplinary,chemistry, physical,nanoscience & nanotechnology
Recent Advances in Developing Active Targeting and Multi-Functional Drug Delivery Systems Via Bioorthogonal Chemistry

Wenzhe Yi,Ping Xiao,Xiaochen Liu,Zitong Zhao,Xiangshi Sun,Jue Wang,Lei Zhou,Guanru Wang,Haiqiang Cao,Dangge Wang,Yaping Li

DOI: https://doi.org/10.1038/s41392-022-01250-1

IF: 39.3

2022-01-01

Signal Transduction and Targeted Therapy

Abstract:Bioorthogonal chemistry reactions occur in physiological conditions without interfering with normal physiological processes. Through metabolic engineering, bioorthogonal groups can be tagged onto cell membranes, which selectively attach to cargos with paired groups via bioorthogonal reactions. Due to its simplicity, high efficiency, and specificity, bioorthogonal chemistry has demonstrated great application potential in drug delivery. On the one hand, bioorthogonal reactions improve therapeutic agent delivery to target sites, overcoming off-target distribution. On the other hand, nanoparticles and biomolecules can be linked to cell membranes by bioorthogonal reactions, providing approaches to developing multi-functional drug delivery systems (DDSs). In this review, we first describe the principle of labeling cells or pathogenic microorganisms with bioorthogonal groups. We then highlight recent breakthroughs in developing active targeting DDSs to tumors, immune systems, or bacteria by bioorthogonal chemistry, as well as applications of bioorthogonal chemistry in developing functional bio-inspired DDSs (biomimetic DDSs, cell-based DDSs, bacteria-based and phage-based DDSs) and hydrogels. Finally, we discuss the difficulties and prospective direction of bioorthogonal chemistry in drug delivery. We expect this review will help us understand the latest advances in the development of active targeting and multi-functional DDSs using bioorthogonal chemistry and inspire innovative applications of bioorthogonal chemistry in developing smart DDSs for disease treatment.
Metal-free Bioorthogonal Click Chemistry in Cancer Theranostics

Dan Wu,Kuikun Yang,Zhankui Zhang,Yunxuan Feng,Lang Rao,Xiaoyuan Chen,Guocan Yu

DOI: https://doi.org/10.1039/d1cs00451d

IF: 46.2

2022-01-01

Chemical Society Reviews

Abstract:Bioorthogonal chemistry is a powerful tool to site-specifically activate drugs in living systems. Bioorthogonal reactions between a pair of biologically reactive groups can rapidly and specifically take place in a mild physiological milieu without perturbing inherent biochemical processes. Attributed to their high selectivity and efficiency, bioorthogonal reactions can significantly decrease background signals in bioimaging. Compared with metal-catalyzed bioorthogonal click reactions, metal-free click reactions are more biocompatible without the metal catalyst-induced cytotoxicity. Although a great number of bioorthogonal chemistry-based strategies have been reported for cancer theranostics, a comprehensive review is scarce to highlight the advantages of these strategies. In this review, recent progress in cancer theranostics guided by metal-free bioorthogonal click chemistry will be depicted in detail. The elaborate design as well as the advantages of bioorthogonal chemistry in tumor theranostics are summarized and future prospects in this emerging field are emphasized.
Integration of Palladium Nanoparticles with Surface Engineered Metal–Organic Frameworks for Cell-Selective Bioorthogonal Catalysis and Protein Activity Regulation

Xianghan Chen,Weiqi Cai,Ji Liu,Lanqun Mao,Ming Wang

DOI: https://doi.org/10.1021/acsami.1c23213

2022-02-18

Abstract:Bioorthogonal catalysis provides a powerful tool to perform non-natural chemical reactions in living systems to dissect complex intracellular processes. Its potency to precisely regulate cellular function, however, is limited by the lack of bioorthogonal catalysts with cell selectivity. Herein, we report that palladium nanoparticles deposited on metal-organic frameworks, Pd@UiO-66, are highly efficient for intracellular bioorthogonal catalysis. In addition, introducing a cancer cell-targeting aptamer, AS1411, onto Pd@UiO-66 enables a threefold enhancement of catalysis efficiency in cancer cells. Moreover, AS1411@Pd@UiO-66 is effective in activating chemically caged 4-hydroxytamoxifen to regulate the activity of a protein destabilizing domain, ER50, and therefore protein function selectively in cancer cells. We show that the control over the activity of a bacterial effector, OspF, using AS1411@Pd@UiO-66 inactivates mitogen-activated protein kinase (MAPK) signaling of cancer cells to selectively prohibit tumor cell growth. We believe that the strategy developed herein for cell-selective bioorthogonal catalysis can expand the chemical biology toolbox for spatiotemporal control of protein function for advanced therapeutic applications.

materials science, multidisciplinary,nanoscience & nanotechnology
Development and Applications of Bioorthogonal Cleavage Reactions

Wang Jie,Chen Peng

DOI: https://doi.org/10.6023/a17090419

2017-01-01

Acta Chimica Sinica

Abstract:Bioorthogonal reactions enable us to study and manipulate biological processes under living conditions. As widely used and powerful tools, biorthogonal reactions are largely defined as "ligation reactions" that are used for labeling, tracing and capturing biomolecules. Recently, an emerging collection of biorthogonal "bond-cleavage reactions" have been developed and applied for biological studies, especially in releasing, activating and manipulating biomolecules. In this review, we will first summarize the characteristics and applications of these biorthogonal cleavage reactions. We will then focus on introducing diverse applications of biorthogonal cleavage reactions, including activation of prodrugs, rescue of intracellular protein activity, engineering of cell surface, among other interesting applications. Finally, the outlook of future development and applications of biorthogonal cleavage reactions will be discussed.
Transition metal-mediated bioorthogonal protein chemistry in living cells.

Maiyun Yang,Jie Li,Peng R Chen

DOI: https://doi.org/10.1039/c4cs00117f

IF: 46.2

2014-01-01

Chemical Society Reviews

Abstract:Considerable attention has been focused on improving the biocompatibility of Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC), a hallmark of bioorthogonal reaction, in living cells. Besides creating copper-free versions of click chemistry such as strain promoted azide-alkyne cycloaddition (SPAAC), a central effort has also been made to develop various Cu(I) ligands that can prevent the cytotoxicity of Cu(I) ions while accelerating the CuAAC reaction. Meanwhile, additional transition metals such as palladium have been explored as alternative sources to promote a bioorthogonal conjugation reaction on cell surface, as well as within an intracellular environment. Furthermore, transition metal mediated chemical conversions beyond conjugation have also been utilized to manipulate protein activity within living systems. We highlight these emerging examples that significantly enriched our protein chemistry toolkit, which will likely expand our view on the definition and applications of bioorthogonal chemistry.
Theranostic platforms for specific discrimination and selective killing of bacteria

Xiaoting Ye,Tao Feng,Lin Li,Tengjiao Wang,Peng Li,Wei Huang

DOI: https://doi.org/10.1016/j.actbio.2021.02.010

IF: 10.633

2021-04-01

Acta Biomaterialia

Abstract:<p>Bacterial infections are serious threats to public health due to lack of advanced techniques to rapidly and accurately diagnose these infections in clinics. Although bacterial infections can be treated with broad-spectrum antibiotics based on empirical judgment, the emergence of antimicrobial resistance has attracted global attention due to long-term misuse and abuse of antibiotics by humans in recent decades. Therefore, it is imperative to selectively discriminate and precisely eliminate pathogenic bacteria. Herein, in addition to the conventional methods for bacterial identification, we comprehensively reviewed the recently developed theranostic platforms for specific discrimination and selective killing of bacteria according to their different interactions with the target bacteria, such as electrostatic and hydrophobic interactions, molecular recognition, microenvironment response, metabolic labeling, bacteriophage targeting, and others. These theranostic agents not only benefit from improved therapeutic efficiency but also present limited susceptibility to induce bacterial resistance. The strategies summarized in this review will open up new avenues in developing effective antimicrobial materials to accurately diagnose and treat bacterial infections in the post-antibiotic era.</p>

engineering, biomedical,materials science, biomaterials
Bioorthogonal chemistry in metal clusters: a general strategy for the construction of multifunctional probes for bioimaging in living cells and in vivo

Xueqian Chen,Yong Zhang,Qing Yuan,Mingrui Li,Yongning Bian,Dongdong Su,Xueyun Gao

DOI: https://doi.org/10.1039/d1tb00836f

IF: 7.571

2021-01-01

Journal of Materials Chemistry B

Abstract:Bioorthogonal chemistry in metal clusters: a new strategy for the preparation of modular multifunctional probes based on the bioorthogonal reaction system is presented.

materials science, biomaterials
Bioorthogonal chemistry-driven anticancer nanotherapeutics

Hongyuan Zhang,Jing Wang,Ruonan Han,Bingjun Sun,Cong Luo

DOI: https://doi.org/10.1016/j.trechm.2023.05.006

IF: 22.448

2023-06-01

Trends in Chemistry

Abstract:Bioorthogonal chemistry has emerged as a promising approach for anticancer applications, enabling targeted tumor detection, imaging, and therapeutic interventions. Particularly, the ingenious encounter of bioorthogonal chemistry and biomedical nanotechnology has opened up new avenues for precise diagnosis and treatment of malignant tumors. Given the remarkable advancements in bioorthogonal chemistry-driven anticancer nanotherapeutics, it is imperative to review the latest breakthroughs. Herein, we aim to outline the emerging trends in the fields at the intersection of bioorthogonal chemistry and biomedical nanotechnology for precision cancer theranostics, with special attention on bioorthogonal chemistry-driven tumor-targeting modalities, nanoprobes, and nanomedicines. This review underscores the rationale, advantages, and challenges of integrating bioorthogonal chemistry with biomedical nanotechnology and tumor biology to develop desirable anticancer nanotherapeutics.

chemistry, multidisciplinary
Progress in the Bioorthogonal Labeling Reactions

Yang Maiyun,Peng R. Chen

DOI: https://doi.org/10.6023/a15030214

2015-01-01

Abstract:Selective labeling of biomolecules inside living cells is a challenging task, which requires the reaction to proceed efficiently and selectively under physiological condition without interfering with active species presented in the living systems. Bioorthogonal reactions, which were developed in the past decade, successfully meet these requirements and their applications in biomolecule labeling have expanded our understanding of cellular process. Considerable attention has been focused on the optimization of a few known bioorthogonal reactions, including discovery of new ligands and privileged substrates for transition metal catalyzed reactions, and the use of strain promoted functional group for substrate activation in the cycloaddition reactions. In addition, new bioorthogonal reactions, including the fluorogenic reactions, have also been emerged in the past few years. Progress has also been made toward the development of mutually exclusive bioorthogonal reactions and their application for multiple labeling of biomolecules inside living cells. Here we review the most widely used bioorthogonal labeling reactions, drawing particular attention to those that have been used in living systems. We focused on the selective labeling of target proteins by means of site-specific introduction of a functional group followed by the bioorthogonal reaction with a complementary functional group. We categorized these reactions into three different groups based on the catalysts used in the reactions: metal catalyzed reactions, photo induced reactions and reactions without catalyst. The biological applications of these bioorthogonal reactions have also been briefly introduced. We also listed the rate constants and main references of these reactions to facilitate researchers for choosing the appropriate one. Lastly, we highlight ongoing challenges in developing new bioorthogonal reactions and their application to study complex biological systems.
Building bioorthogonal click-release capable artificial receptors on cancer cell surface for imaging, drug targeting and delivery

Jing Chen,Peng Ji,Giri Gnawali,Mengyang Chang,Feng Gao,Hang Xu,Wei Wang

DOI: https://doi.org/10.1016/j.apsb.2022.12.018

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:The current targeting drug delivery mainly relies on cancer cell surface receptors. However, in many cases, binding affinities between protein receptors and homing ligands is relatively low and the expression level between cancer and normal cells is not significant. Distinct from conventional targeting strategies, we have developed a general cancer targeting platform by building artificial receptor on cancer cell surface via a chemical remodeling of cell surface glycans. A new tetrazine (Tz) functionalized chem-ical receptor has been designed and efficiently installed on cancer cell surface as "overexpressed" biomarker through a metabolic glycan engineering. Different from the reported bioconjugation for drug targeting, the tetrazine labeled cancer cells not only locally activate TCO-caged prodrugs but also release active drugs via the unique bioorthogonal Tz-TCO click-release reaction. The studies have demonstrated that the new drug targeting strategy enables local activation of prodrug, which ultimately leads to effec-tive and safe cancer therapy. & COPY; 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Bioorthogonal Catalysis for Biomedical Applications

Tingxizi Liang,Zhaowei Chen,Hongjun Li,Zhen Gu

DOI: https://doi.org/10.1016/j.trechm.2021.11.008

IF: 22.448

2022-01-01

Trends in Chemistry

Abstract:Bioorthogonal catalysts based on metal complexes have gained substantial progress during recent years. Diversified delivery routes, including nanoparticles, hydrogels, exosomes, and removable microneedle patches, have provided efficient and biocompatible ways for in vivo transportation of bioorthogonal systems. A proximal decaging strategy via biorthogonal catalysis achieved time-resolved protein activation in living systems and enriched the toolbox for indirect protein engineering. The efficacy of bioorthogonal catalysis has been explored in the activation of antimicrobial reagents. Bioorthogonal catalysis has been applied to cell engineering by triggering the transformation of chemical groups on cell membranes, thus providing a feasible toolkit to regulate cell status. Bioorthogonal chemistry, referring to chemical reactions occurring in a physiological environment without interfering with native biochemical reactions, has witnessed substantial progress during the past few decades. To date, bioorthogonal chemistry has achieved wide applications in biomedical practices, including prodrug activation, protein transformation, and cellular engineering. Here, we review the development and recent advances of bioorthogonal chemistry, with an emphasis on the biomedical application of bioorthogonal catalysis, aiming to provide an overview of the evolution and challenges in this field. Bioorthogonal chemistry, referring to chemical reactions occurring in a physiological environment without interfering with native biochemical reactions, has witnessed substantial progress during the past few decades. To date, bioorthogonal chemistry has achieved wide applications in biomedical practices, including prodrug activation, protein transformation, and cellular engineering. Here, we review the development and recent advances of bioorthogonal chemistry, with an emphasis on the biomedical application of bioorthogonal catalysis, aiming to provide an overview of the evolution and challenges in this field. cycloaddition reaction that takes place between electron-rich dienophile and electron-deficient diene. a strategy that could covalently attach molecules to nucleophilic amino acid residues located near the ligand-binding site. a modification of the classic Staudinger reduction of azides with triphenylphosphine. metal-free cycloadditions between strained cyclooctynes and azides that give stable 1,2,3-triazoles.
Bacteria-Mediated Intracellular Click Reaction for Drug Enrichment and Selective Apoptosis of Drug-Resistant Tumor Cells

Zhiqiang Gao,Endong Zhang,Hao Zhao,Shengpeng Xia,Haotian Bai,Yiming Huang,Fengting Lv,Libing Liu,Shu Wang

DOI: https://doi.org/10.1021/acsami.2c01493

2022-03-08

Abstract:Functionalized biocarriers that can perform bio-orthogonal reactions in tumor cells may provide solutions to overcome the efflux of the chemotherapeutic agent from drug-resistant tumor cells. Herein, we report the enrichment of therapeutic drugs in tumor cells through intracellular click reaction with functionalized bacteria. Specifically, an intracellular bioactive drug enrichment template (Escherichia coli) is constructed by combining positively charged oligo(phenylene-vinylene)-alkyne (OPV–C≡CH) with E. coli via electrostatic interaction. After the cell uptake of E. coli and Cu(II)-based complex, Cu(I) generated in situ can catalyze the bio-orthogonal click reaction to covalently anchor the azide-bearing molecules of cyanine 5 (Cy5-N3) and paclitaxel (PTX-N3) on E. coli. These molecules and their functions were retained and enriched inside the drug-resistant tumor cells A549T, which can label cells with fluorescent probes and selectively induce the apoptosis of drug-resistant tumor cells.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.2c01493.NMR spectra of OPV–C≡CH and PTX-N3, bacterial growth curve, CLSM images, cell viability, NMR spectra of "click" product, GSH standard curve, and the conversion rate of Cu(I) under different concentrations of GSH (PDF)This article has not yet been cited by other publications.

materials science, multidisciplinary,nanoscience & nanotechnology
Smart Bioorthogonal Nanozymes: From Rational Design to Appropriate Bioapplications

Wenting Zhang,Jiawei Zhu,Jinsong Ren,Xiaogang Qu

DOI: https://doi.org/10.1002/adma.202405318

IF: 29.4

2024-08-19

Advanced Materials

Abstract:This review summarizes the recent advances in the design of smart bioorthogonal nanozymes with a unique focus on regulating and improving their catalytic activity to achieve better performance in living systems. In addition, the current challenges and perspectives in this thriving field are discussed, expecting to inspire further application and facilitate their future clinical translation. Bioorthogonal chemistry has provided an elaborate arsenal to manipulate native biological processes in living systems. As the great advancement of nanotechnology in recent years, bioorthogonal nanozymes are innovated to tackle the challenges that emerged in practical biomedical applications. Bioorthogonal nanozymes are uniquely positioned owing to their advantages of high customizability and tunability, as well as good adaptability to biological systems, which bring exciting opportunities for biomedical applications. More intriguingly, the great advancement in nanotechnology offers an exciting opportunity for innovating bioorthogonal catalytic materials. In this comprehensive review, the significant progresses of bioorthogonal nanozymes are discussed with both spatiotemporal controllability and high performance in living systems, and highlight their design principles and recent rapid applications. The remaining challenges and future perspectives are then outlined along this thriving field. It is expected that this review will inspire and promote the design of novel bioorthogonal nanozymes, and facilitate their clinical translation.

materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
Bioorthogonal Chemistry for Site-Specific Labeling and Surface Immobilization of Proteins

Yong-Xiang Chen,Gemma Triola,Herbert Waldmann

DOI: https://doi.org/10.1021/ar200046h

IF: 24.466

2011-01-01

Accounts of Chemical Research

Abstract:Understanding protein structure and function is essential for uncovering the secrets of biology, but it remains extremely challenging because of the high complexity of protein networks and their wiring. The daunting task of elucidating these interconnections requires the concerted application of methods emerging from different disciplines. Chemical biology integrates chemistry, biology, and pharmacology and has provided novel techniques and approaches to the investigation of biological processes. Among these, site-specific protein labeling with functional groups such as fluorophors, spin probes, and affinity tags has greatly facilitated both in vitro and in vivo studies of protein structure and function. Bioorthogonal chemical reactions, which enable chemo- and regioselective attachment of small-molecule probes to proteins, are particularly attractive and relevant for site-specific protein labeling. The introduction of powerful labeling techniques also has inspired the development of novel strategies for surface immobilization of proteins to create protein biochips for in vitro characterization of biochemical activities or interactions between proteins. Because this process requires the efficient immobilization of proteins on surfaces while maintaining structure and activity, tailored methods for protein immobilization based on bioorthogonal chemical reactions are in high demand. In this Account, we summarize recent developments and applications of site-specific protein labeling and surface immobilization of proteins, with a special focus on our contributions to these fields. We begin with the Staudinger ligation, which involves the formation of a stable amide bond after the reaction of a preinstalled azide with a triaryl phosphine reagent. We then examine the Diels-Alder reaction, which requires the protein of interest to be functionalized with a diene, enabling conjugation to a variety of dienophiles under physiological conditions. In the oxime ligation, an oxyamine is condensed with either an aldehyde or a ketone to form an oxime; we successfully pursued the inverse of the standard technique by attaching the oxyamine, rather than the aldehyde, to the protein. The click sulfonamide reaction, which involves the Cu(I)-catalyzed reaction of sulfonylazides with terminal alkynes, is then discussed. Finally, we consider in detail the photochemical thiol-ene reaction, in which a thiol adds to an ene group after free radical initiation. Each of these methods has been successfully developed as a bioorthogonal transformation for oriented protein immobilization on chips and for site-specific protein labeling under physiological conditions. Despite the tremendous progress in developing such transformations over the past decade, however, the demand for new bioorthogonal methods with improved kinetics and selectivities remains high.
Unnatural Amino Acid Mediated Protein Bioorthogonal Labeling

Jie Li,Jie Wang,Peng R. Chen

DOI: https://doi.org/10.6023/a12050263

2012-01-01

Abstract:The bioorthogonal chemistry has become a valuable tool for specific labeling of biomolecules in living systems. One emerging example is to convert the palladium-mediated carbon-carbon bond formation reaction, a landmark reaction in organic synthesis, into the biocompatible reaction for biomolecule modifications. A prerequisite to enable such reactions to be executed on biological samples is to incorporate the corresponding bioorthogonal functional groups into target biomolecules. The genetic code expansion strategy is a leading technology on introducing diverse bioorthogonal functionalities into proteins, and the most recently developed pyrrolysine system can now allow unnatural amino acids (UAAs) bearing bioorthogonal handles into proteins in prokaryotic cells, etikaryotic cells and even in living animals. In this perspective, we will first introduce some of the forefronts of the bioorthognal reactions as well as the genetic code expansion strategy. We then will discuss the advantages and attractiveness of combining these newly emerged tools, Pd-mediated biomolecular labeling and pyrrolysine-based genetic code expansion system in particular, to specifically label and study proteins in living mammalian cells. More biocompatible reactions and more flexible UAA incorporation system will significantly strengthen and expand our ability to specifically manipulate proteins in their native cellular environment.

Bioorthogonal chemistry for selective recognition, separation and killing bacteria over mammalian cells.

Selective treatment of intracellular bacterial infections using host cell-targeted bioorthogonal nanozymes

On-Demand Activatable and Integrated Bioorthogonal Nanocatalyst against Biofilm-Associated Infections

Bioorthogonal reactions and AIEgen-based metabolically engineered theranostic systems

Bioorthogonal Reactions in Bioimaging

Antibody Mimics as Bio-orthogonal Catalysts for Highly Selective Bacterial Recognition and Antimicrobial Therapy

Recent Advances in Developing Active Targeting and Multi-Functional Drug Delivery Systems Via Bioorthogonal Chemistry

Metal-free Bioorthogonal Click Chemistry in Cancer Theranostics

Integration of Palladium Nanoparticles with Surface Engineered Metal–Organic Frameworks for Cell-Selective Bioorthogonal Catalysis and Protein Activity Regulation

Development and Applications of Bioorthogonal Cleavage Reactions

Transition metal-mediated bioorthogonal protein chemistry in living cells.

Theranostic platforms for specific discrimination and selective killing of bacteria

Bioorthogonal chemistry in metal clusters: a general strategy for the construction of multifunctional probes for bioimaging in living cells and in vivo

Bioorthogonal chemistry-driven anticancer nanotherapeutics

Progress in the Bioorthogonal Labeling Reactions

Building bioorthogonal click-release capable artificial receptors on cancer cell surface for imaging, drug targeting and delivery

Bioorthogonal Catalysis for Biomedical Applications

Bacteria-Mediated Intracellular Click Reaction for Drug Enrichment and Selective Apoptosis of Drug-Resistant Tumor Cells

Smart Bioorthogonal Nanozymes: From Rational Design to Appropriate Bioapplications

Bioorthogonal Chemistry for Site-Specific Labeling and Surface Immobilization of Proteins

Unnatural Amino Acid Mediated Protein Bioorthogonal Labeling